Assessment of the antioxidant activity of the SH metabolite I of erdosteine on human neutrophil oxidative bursts;Antioxidans-aktivitat des SH-metaboliten I von erdostein bei oxidativen bursts menschlicher neutrophilen

Arzneimittel-Forschung/Drug Research

Volumn 50, Issue 8, 2000, Pages 739-746

  Braga, P C ^a   Dal Sasso, M ^a   Zuccotti, T ^a  

^a Department of Pharmacology ^*  (Italy)

Author keywords

Antioxidant activity of metabolite I; Antioxidants; CAS 84611 23 4; Erdosteine; N Acetylcysteine

Indexed keywords

ACETYLCYSTEINE; ERDOSTEINE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL FREE SYSTEM; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG METABOLISM; HUMAN; HUMAN CELL; NEUTROPHIL; OXIDATIVE STRESS; RESPIRATORY BURST;

EID: 0033884335     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300281     Document Type: Article

References (66)

1. An introduction to free radical biochemistry
2. Formation of free radicals and mechanisms of action in normal biochemical processes and pathological states
3. Some chemical and biochemical constraints of oxidative stress in living cells
4. Oxygen radical damage in biological systems
5. Biology of disease: Free radicals and tissue inury
6. Membrane lipids as a preferential target for oxidative process
7. DNA oxidation: Characterization of the damage and mechanistic aspect
8. Vitamin C in respiratory disease
9. Design and morphometry of the pulmonary gas exchanger
10. General environment. Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract
11. Oxidants and respiratory tract epithelial injury: Pathogenesis and strategies for therapeutic intervention
12. Neutrophil enzymes and emphysema
13. The pathogenesis and significance of bronchial hyperresponsiveness in airways
14. Asthma and inflammation
15. Role of inflammation in the hyperreactivity of the airways in asthma
16. Oxidative stress in cystic fibrosis: Does it occur and does it matter?
17. Cystic fibrosis
18. In vitro evaluation of the ability of glutathione to suppress the inflammatory cell derived oxidant burden in respiratory epithelial lining fluid of individuals with cystic fibrosis
19. Adult respiratory distress syndrome: A radicale perspective
20. Tissue injury in inflammation. Oxidants proteinases and cationic proteins
21. Oxidant activity in expired breath of patients with adult respiratory distress syndrome
22. Circulating immune complex in the idiopathic interstitial pneumonias
23. Neutrophils and the pathogenesis of idiopathic pulmonary fibrosis
24. Exposure to asbestos and human disease
25. Generation of free radicals from freshly fractured silica dust
26. Crocidolite-induced lipid peroxidation
27. Nitrofurantoin: Evidence for the oxidant injury of lung parenchyma cells
28. In vitro stimulation by paraquat of reactive oxygen-mediated lipid peroxidation in rat lung microsomes
29. Citotoxic drug-induced pulmonary disease: Update 1980
30. The production of hydroxyl radical by bleomycin and iron (II)
31. Suttorp, Lung cell oxidant injury: Decrease in oxidant mediated cytotoxicity by N-acetylcysteine
32. Inhibitory effects of N-acetylcysteine on superoxide anion generation in human polymorphonuclear leukocytes
33. Effect of oral N-acetylcysteine administration on human blood neutrophil and monocyte function
34. Effects of erdosteine and its metabolites on bacterial adhesiveness
35. Influence of antibiotics on formylmethionyl-leucyl-phenylalanine-induced leukocyte chemiluminescence
36. Mechanism of the luminol-dependent chemiluminescence of human neutrophils
37. N-acetylcysteine inhibits human neutrophil and monocyte chemotaxis and oxidative metabolism
38. Intra- and extracellular events in luminol-dependent chemiluminescene of polymorphonuclear leukocytes
39. Chemiluminescence response to pathogenic organisms: Normal human polymorphonuclear leukocytes
40. Enhanced chemiluminescence assay for antioxidant capacity in biological fluids
41. An investigation of the antioxidant activity of black tea using enhanced chemiluminescence
42. Effect of antimicrobial agents on chemiluminescence of human polymorphonuclear leukocytes in response to phagocytosis
43. Luminol chemiluminescence chemistry, excitation, emitter
44. Oxidation of luminol by chlorine dioxide: Formation of 5-aminophthalazine-1,4-dione
45. Co-oxidation of luminol by hypochlorite and hydrogen peroxide. Implications for neutrophil chemiluminescence
46. Mechanisms of inhibition of chemiluminescence in the oxidation of luminol by sodium hypochlorite
47. Pathogenesis of airway mucus hypersecretion
48. Free radical scavengers as anti-inflammatory drugs?
49. Oxidants and antioxidants: Pathophysiological determinants and therapeutic agents
50. Acetylcysteine
51. N-acetylcysteine enhances receptor-mediated phagocytosis by human neutrophils
52. Effects of N-acetylcysteine on human polymorphonuclear leukocytes
53. Comparison of in vitro effects of two thio-containing drugs on human neutrophils hydrogen peroxide production
54. In vitro comparative assessment of the antioxidant activity of nacystelyin against three reactive oxygen species
55. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide and hypochlorus acid
56. Thiols as peroxidase substrate
57. Does luminol chemiluminescence detect free radical scavengers?
58. Lung protection by a thiol containing antioxidant N-acetylcysteine
59. The formation of free radicals by cardiac myocytes under oxidative stress and the effects of electron-donating drugs
60. Marked reduction of free radical generation and contractile dysfunction of antioxidant therapy begun at the time of reperfusion. Evidence that myocardial stunning is a manifestation of reperfusion injury
61. Thiol compounds as protective agents in erythrocytes under oxidative stress
62. Antioxidant potential of anaerobic human plasma: Role of serum albumin and thiols as scavengers of carbon radicals
63. Glutathione, free radicals and chemotherapeutic agents. Mechanisms of free-radical induced toxicity and glutathione-dependent protection